Physician profile
William P Patterson
NPI 1952559684
$1,236.58
in general payments reported to CMS, 2019-2025
15 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $326 · 2020: $62.06 · 2021: $188 · 2022: $158 · 2023: $101 · 2024: $93.33 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $503.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $298.06 | 2019-2021 | |
| Coopervision INC. | $223.22 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens |
| Alcon Vision LLC | $217.68 | 2019-2025 | Precision7, Total30, Tryptyr |
| Novartis Pharmaceuticals Corporation | $161.92 | 2019-2023 | |
| Allergan, INC. | $66.09 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $65.57 | 2024-2025 | Xiidra |
| Biotissue Holdings INC. | $39.97 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $31.44 | 2025 | Xdemvy |
| Alcon Research LLC | $30.64 | 2019 | |
| Sight Sciences, INC. | $22.39 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Optos, INC. | $18.36 | 2019 | |
| Abbvie INC. | $16.26 | 2022 | |
| Carl Zeiss Meditec USA, INC. | $13.30 | 2021 | |
| Carl Zeiss Meditec, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.